Fractal pharmacokinetics of the drug mibefradil in the liver

Physical Review E - Statistical Physics, Plasmas, Fluids, and Related Interdisciplinary Topics

Volumn 66, Issue 2, 2002, Pages

  Fuite, J ^a   Marsh, R ^a   Tuszynski J ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL ORGANS; BLOOD; CONCENTRATION (PROCESS); DATA REDUCTION; DRUG PRODUCTS; ENZYMES; FRACTALS; RESPIRATORY SYSTEM; ULTRASONICS;

BIOLOGICAL DESIGN; FRACTAL PHARMACOKINETICS; MIBEFRADIL; MORPHOGENESIS;

PHARMACOKINETICS;

MIBEFRADIL;

ANIMAL; BIOLOGICAL MODEL; DOG; DRUG EFFECTS; FRACTAL ANALYSIS; KINETICS; LIVER; STATISTICAL MODEL; TIME;

ANIMALS; DOGS; FRACTALS; KINETICS; LIVER; MIBEFRADIL; MODELS, BIOLOGICAL; MODELS, STATISTICAL; TIME FACTORS;

EID: 41349104044     PISSN: 1063651X     EISSN: None     Source Type: Journal    
DOI: 10.1103/PhysRevE.66.021904     Document Type: Article

References (53)

1. E. Gladtke and H.M. von Hattingberg, Pharmacokinetics: An Introduction (Springer-Verlag, Berlin, 1979).
2. M.E. Winters, Basic Clinical Pharmacokinetics (Applied Therapeutics, Vancouver, Washington, 1994).
3. M. Gibaldi and D. Perrier, Pharmacokinetics, 2nd ed. (Dekker, New York, 1982).
4. T.L. Schwinghammer and P.D. Kroboth, J. Clin. Pharmacol. 28, 388 (1988).
5. R.H. Levy and L.A. Bauer, Ther. Drug Monit 8, 47 (1986).
6. J.J. DiStefano and E.M. Landaw, Am. J. Physiol. 246, R651 (1984).
7. W.A. Colburn, J. Clin. Pharmacol. 28, 879 (1988).
8. W.R. Gillespie, Clin. Pharmacokinet 20, 243 (1991).
9. P. Macheras, Pharm. Res. 13, 663 (1996).
10. J. B. Bassingthwaighte, L. Liebovitch, and B. West, Fractal Physiology (Oxford University Press, New York, 1994).
11. Fractals in Biology and Medicine, edited by T. Nonnenmacher, G. Losa, and E. Weibel (Birkhäuser Verlag, Basel, 1994).
12. J.B. Bassingthwaighte, R.B. King, and S.A. Roger, Circ. Res. 65, 578 (1989).
13. M.A. Weiss, J. Theor. Biol. 184, 1 (1997).
14. K.M. van der Graff and S.I. Fox, Concepts of Human Anatomy and Physiology, 2nd ed. (W. M. C. Brown, Iowa, 1988).
15. B.J. West and A.L. Goldberger, Am. Sci. 75, 354 (1987).
16. M. Giona, Chem. Eng. Sci. 47, 1503 (1992).
17. S. Havlin and D. Ben-Avraham, Adv. Phys. 36, 695 (1987).
18. R. Kopelman, J. Stat. Phys. 42, 185 (1986).
19. R. Kopelman, Science 241, 1620 (1988).
20. H. Koch, Pharmazie 48, 643 (1993).
21. E. Ragazzi, Pharmazie 50, 66 (1995).
22. A. Skerjanec, S. Tawfik, and Y.K. Tam, J. Pharm. Sci. 85, 189 (1995).
23. H. Wiltshire, B. Sutton, G. Heeps, A. Betty, D. Angus, S. Harris, E. Worth, and H. Welker, Xenobiotica 27, 557 (1997).
24. H.A. Welker, J. Pharm. Pharmacol. 50, 983 (1998).
25. J.L. Campra and T.B. Reynolds, in The Liver: Biology and Pathobiology, edited by I.M. Arias, H. Popper, D. Schachter, and D.A. Shafritz, 1st ed. (Raven Press, New York, 1982).
26. W.W. Loutt and M.P. Macedo, Drug Metab. Rev. 29, 369 (1997).
27. H. Elias, in The Liver: Morphology, Biochemistry, Physiology, edited by C. Rouiller (Academic Press, New York, 1963), Vol. I.
28. R.W. Glenny and H.T. Robertson, J. Appl. Physiol. 69, 532 (1990).
29. R.W. Glenny and H.T. Robertson, J. Appl. Physiol. 70, 1024 (1991).
30. M. Sernetz, J. Wubbeke, and P. Wlczek, Physica A 191, 13 (1992).
31. B. B. Mandelbrot, The Fractal Geometry of Nature (Freenan, San Francisco, 1977).
32. C. Javanaud, J. Acoust. Soc. Am. 86, 493 (1989).
33. Y.-E. Koo and R. Kopelman, J. Stat. Phys. 65, 185 (1986).
34. R. Kopelman, A. Lin, and P. Argyrakis, Phys. Lett. A 232, 34 (1997).
35. K.F. Eckerman, R.W. Leggett, and L.R. Williams, Radiat. Prot. Dosim. 41, 257 (1992).
36. F. Farris, R. Dedrick, P. Allen, and J. Smith, Toxicol. Appl. Pharmacol. 119, 74 (1993).
37. M.R. Rowland and A.M. Evans, in New Trends in Pharmacokinetics, Vol. 221 of NATO Advanced Study Institute, Series A:Life Sciences, edited by Aldo Resagno and Ajit K. Thakur (Plenum Press, London, 1992), pp. 83–115.
38. K.-C.T. Hoang, Toxicol. Lett. 79, 99 (1995).
39. H. Boxenbaum, Drug Metab. Rev. 24, 89 (1992).
40. L. Gerlowski and R. Jain, J. Pharm. Sci. 72, 1103 (1983).
41. R. Redheffer, Differential Equations: Theory and Applications (Jones & Barlett, Boston, 1991), Chap. 17.
42. I. Gradsteyn and I. Ryzhik, Table of Integrals, Series, and Products, 5th ed. (Academic Press, New York, 1994).
43. J.R. Taylor, An Introduction to Error Analysis: The Study of Uncertainties in Physical Measurements (University Science Book, Mill Valley, 1982).
44. D.W.A. Bourne, Mathematical Modeling of Pharmacokinetic Data (Technomic Publishing Company, Lancaster, Pennsylvania, 1995).
45. G.A. Milliken and D.E. Johnson, Analysis of Messy Data, (Chapman and Hall, London, 1992), Vol. I.
46. D.C. Hoaglin, F.M. Mosteller, and J.W. Tukey, Understanding Robust and Exploratory Data Analysis (Wiley, New York, 1983).
47. P.J. Rousseeuw and A.M. Leroy, Robust Regression and Outlier Detection (Wiley, New York, 1987).
48. A. Atkinson and M. Riani, Robust Diagnostic Regression Analysis (Springer-Verlag, New York, 2000).
49. E. Liang and H. Derendorf, J. Pharmacokinet Biopharm. 26, 247 (1998).
50. B.J. West and B. Deering, in The Lure of Modern Science, edited by B.J. West, B. Deering, Bill Deering, and W. Deering, Studies of Nonlinear Phenomena in Life Science Vol. 3 (World Scientific, New Jersey, 1995).
51. E.R. Weibel, C.R. Taylor, and H. Hoppeler, Proc. Natl. Acad. Sci. U.S.A. 88, 10357 (1991).
52. E.R. Weibel, The Pathway for Oxygen (Harvard University Press, Cambridge, Massachusetts, 1984).
53. E.R. Weibel, Symmorphosis (Harvard University Press, Cambridge, Massachusetts, 2000).